InsiderClue
Stocks · Health care · Pharmaceutical Preparations

OnKure Therapeutics, Inc.

OKUR Clue Score34
United States Fiscal year ends December CIK 0001637715 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

20
Insider
Date
Role
Action
Shares
Price
Amount
Jason A. Leverone
21 Sep 2026
Chief Financial Officer
Sell
302
$2.97
$898.21
Nicholas A Saccomano
21 Sep 2026
President and CEO
Sell
87
$2.97
$258.76
Jason A. Leverone
22 Jun 2026
Chief Financial Officer
Sell
303
$4.40
$1.33K
Nicholas A Saccomano
22 Jun 2026
President and CEO
Sell
86
$4.40
$378.08
Jason A. Leverone
23 Mar 2026
Chief Financial Officer
Sell
301
$4.16
$1.25K
Nicholas A Saccomano
23 Mar 2026
President and CEO
Sell
86
$4.16
$357.46
Jason A. Leverone
22 Dec 2025
Chief Financial Officer
Sell
302
$2.97
$896.25
Nicholas A Saccomano
22 Dec 2025
President and CEO
Sell
87
$2.97
$258.19
Jason A. Leverone
22 Sep 2025
Chief Financial Officer
Sell
303
$2.62
$794.92
Nicholas A Saccomano
22 Sep 2025
President and CEO
Sell
88
$2.62
$230.87
Jason A. Leverone
23 Jun 2025
Chief Financial Officer
Sell
303
$2.38
$722.41
Nicholas A Saccomano
23 Jun 2025
President and CEO
Sell
88
$2.38
$209.81
Cormorant Asset Management, LP
15 May 2025
Former 10% Owner
Sell indirect
1,813,439
$1.85
$3.36M
Cormorant Asset Management, LP
12 May 2025
10% owner
Sell indirect
24,300
$1.99
$48.24K
Jason A. Leverone
7 Apr 2025
Chief Financial Officer
Sell
1,844
$2.67
$4.93K
Nicholas A Saccomano
7 Apr 2025
President and CEO
Sell
516
$2.67
$1.38K
Jason A. Leverone
4 Apr 2025
Chief Financial Officer
Sell
1,278
$3.33
$4.25K
Nicholas A Saccomano
4 Apr 2025
President and CEO
Sell
358
$3.33
$1.19K
Novo Holdings A/S
23 Jun 2023
10% owner
Sell
100,000
$7.10
$709.74K
Wendy S. Johnson
14 Jul 2021
Chief Development Officer
Sell
111,736
$8.50
$949.76K
Show all 61 transactions →

What was left out

Form 4 filings counted 133
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 13,328,761
Sales filed before the plan box existed 1
History held since 12 Apr 2021